Start Date
February 29, 1996
Study Completion Date
May 31, 2003
aldesleukin
mutant p53 peptide pulsed dendritic cell vaccine
ras peptide cancer vaccine
sargramostim
therapeutic autologous lymphocytes
therapeutic tumor infiltrating lymphocytes
Medicine Branch, Bethesda
National Cancer Institute (NCI)
NIH